Acutaas Chemicals (ACUTAAS) investor relations material

Business overview and market position

• Offers over 610 products, serving ~600 customers in 55+ countries across pharmaceuticals, semiconductors, battery, and commodity chemicals.

• Holds 50–90% global market share in key pharmaceutical intermediates and is India's only manufacturer of photoresist chemicals.

• Operates five manufacturing facilities, with ongoing expansion in South Korea for advanced semiconductor chemicals.

• Over 90% of products are backward integrated to basic chemicals, ensuring supply chain control.

• Achieved EcoVadis Platinum rating, reflecting top-tier sustainability practices.

Strategic evolution and milestones

• Transitioned from a small lab in 1998 to a global specialty chemicals leader, with major expansions and acquisitions from 2004 to 2025.

• Entered new verticals such as battery additives and semiconductors through acquisitions and joint ventures.

• Surpassed ₹10,000 million in sales in 2025 and rebranded to reflect a focus on specialty and custom solutions.

• Recognized for innovation, export performance, and leadership, with multiple industry awards.

Business segments and differentiation

• Pharmaceutical intermediates: Focus on CDMO, chronic therapies, and early off-patent product development; 95% of products serve chronic segments.

• Specialty chemicals: Only Indian supplier of photoresist chemicals, with advanced purity and niche market focus.

• Battery chemicals: First Indian manufacturer of electrolyte additives, with strong export orientation and 10+ products in pipeline.

• Commodity chemicals: Over 400 customers, portfolio diversification, and resilience during global overcapacity.